06:04 EDT Portage Biotech (PRTG) files $40M mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRTG:
- Portage Biotech Announces Preclinical Success for PORT-7 in Mesothelioma
- Portage Biotech’s PORT-7 shows efficacy in mesothelioma preclinical study
- Portage Biotech trading resumes
- Portage Biotech trading halted, volatility trading pause
- Portage Biotech Announces Promising Preclinical Results for PORT-7 in Mesothelioma
